All news updates:

Feb 16, 2024 | Katleen Vandersmissen
Laurens de Vries joins HERAN Partners as Analyst
Laurens de Vries supports the HERAN team in focussing on investment opportunities and mapping market segments, in order to actively source innovative ventures.
Sep 19, 2023 | Katleen Vandersmissen
13th Investment for HERAN Partners: Broken String Biosciences (UK)
HERAN Partners invests in Broken String Biosciences: a genomics company building a technology platform to drive the development of cell and gene therapies.
Sep 14, 2023 | Katleen Vandersmissen
Thirona secures EUR 7,5m via investment round and EIC grant
Thirona raises EUR 7,5m in new financing round to accelerate the adoption of its breakthrough innovations for precision medicine
Sep 05, 2023 | Katleen Vandersmissen
FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO
New CEO Mark Truesdale will bring the disruptive technology of FOx Biosystems to a wider audience and ensure its further success
Jun 01, 2023 | Katleen Vandersmissen
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
HERAN Partners co-leads the GBP 6,5M financing round of Hypervision Surgical: a London-based venture building an advanced surgical imaging and data analytics platform.
Apr 14, 2023 | Katleen Vandersmissen
Discover how a sound collaboration between a start-up and a Venture Capital fund drives innovation in healthcare: FOx Biosystems case study
We take a look behind the scenes of an ambitious start-up and investors in the HealthTech field by going into conversation with Thomas Van Elzakker, CEO of FOx Biosystems and Katleen Vandersmissen, Managing Partner at HERAN Partners.
Mar 24, 2023 | Katleen Vandersmissen
HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform
HERAN Partners is pleased to announce its investment in ImmuneSpec, a Company at the forefront of advanced immunopeptidomics. The EUR 1,2m seed funding from HERAN HealthTech Fund I will enable ImmuneSpec to accelerate the further optimisation and commercial roll-out of their advanced immunopeptidomics analysis platform.
Mar 13, 2023 | Katleen Vandersmissen
6 questions for SMEs and start-ups looking to become more sustainable: 'Find the right balance between workload and impact'
Want to make your SME or start-up more sustainable, but don't have the resources for a sustainability manager? During a recent double interview with Trends magazine, Charlotte Vandierendonck of the consulting firm Studio D and HERAN Partners managing director Katleen Vandersmissen answered six questions to help you get started.
Jan 13, 2023 | Katleen Vandersmissen
FOx BIOSYSTEMS raises €5,8 million in a Series B-round
The additional raised capital will be used to scale up the company’s operations, accelerate the development of new application areas and further boost commercialization.

Join a Heran Fund

We are open to novel investments and are always planning the next funds and investment strategies. Leave your details below and our partners will be in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Pitch your company

Submit your pitch below. We receive dozens of pitches each week and process these dilligently. We might not be able to get back to you immediately.

Max file size 10MB.
Upload failed. Max size for files is 10 MB.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.